Photodynamic therapy consists of the uptake of a photosensitizing dye, often a porphyrin, by tumor tissue and subsequent irradiation of the tumor with visible light of an appropriate wavelength matched to the absorption spectrum of the photosensitizing dye. This class of molecules produces reactive oxygen species when activated by light, resulting in a direct or indirect cytotoxic effect on the target cells. Photodynamic therapy has been used in the treatment of cancer but the technology has a potential for the treatment of several disease conditions mainly because of its selectivity. However, it is not clear why the porphyrins are retained preferentially by abnormal tissue. This paper describes a study of the effect of the association of porphyrin and visible light on two mouse fibroblast cell lines: A31, normal cells and B61, an EJ-ras transformed variant of A31. Two water-soluble porphyrins were used, a positively charged one, tetra(N-methyl-4-pyridyl)porphyrin chloride, and a negatively charged one, tetra(4-sulfonatophenyl)porphyrin-Na salt (TPPS 4 ) in order to assess the effect on cell survival. The results suggest that the B61 cell line is more sensitive to incubation with the anionic porphyrin (TPPS 4 ) followed by light irradiation and that the anionic porphyrin is more efficient in killing the cells than the cationic porphyrin.
Studies that aim to produce flexible films of composite materials based on ionomers-PZT, and volume fractions lower than 10% PZT, in order to monitor damage in aeronautical structures are seldom investigated. The growing emphasis on the use of polymers capable of self-healing after damage or activation by heating has motivated the application of self-healing ionomers as polymeric matrices in composites with piezoelectric particles aiming to monitor damage. Flexible composite films were developed based on the self-healing polymer matrix Surlyn® 8940 ionomer (DuPontTM—Wilmington, DE, USA) and PZT particles (connectivity 2–3) in volume fractions of 1, 3, 5 and 7%, with thickness around 50–100 µm. The choice of PZT volume fractions followed the preliminary requirement that establishes a final density, which is lower or at least close to the density of the materials used in aeronautical structures. Since the application of composites based on epoxy resin/carbon fibers has been increasing in the aeronautical segment, this material (with density lower than 1500 kg/m3) was chosen as a reference for the present work. Thus, due to self-healing (a characteristic of the matrix Surlyn® 8940) combined with recyclability, high flexibility and low thickness, the flexible composite films showed advantages to be applied on aeronautical structures, which present complex geometries and low-density materials. The manufactured films were characterized by SEM, XRD, DMA and mechanical tensile tests. The results were discussed mainly in terms of the volume fraction of PZT. X-ray diffraction patterns showed coexistent rhombohedral and tetragonal phases in the PZT particles-dispersed composite, which can potentialize the alignment of ferroelectric domains during polarization under strong electrical field, enhancing dielectric and piezoelectric properties toward sensing applications. DMA and tensile testing results demonstrated that the addition of PZT particles did not impair either dynamic or quasi-static mechanical performance of the flexible composite films. It was concluded that the PZT volume fraction should be lower than 3% because, for higher values, the molecular mobility of the polymer would suffer significant reductions. These findings, combined with the high flexibility and low density of the ceramic particle-filled thermoplastic polymer, render the developed flexible composite film a very promising candidate for strain and damage sensing in aeronautical structures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.